featured
Lenvatinib Plus Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
J. Clin. Oncol 2022 Aug 03;[EPub Ahead of Print], Z Peng, W Fan, B Zhu, G Wang, J Sun, C Xiao, F Huang, R Tang, Y Cheng, Z Huang, Y Liang, H Fan, L Qiao, F Li, W Zhuang, B Peng, J Wang, J Li, M KuangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.